alpha-methyl-4-carboxyphenylglycine has been researched along with sr141716 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Novellis, V; Maione, S; Marabese, I; Mariani, L; Palazzo, E; Rossi, F; Scafuro, M; Vita, D | 1 |
1 other study(ies) available for alpha-methyl-4-carboxyphenylglycine and sr141716
| Article | Year |
|---|---|
Periaqueductal grey CB1 cannabinoid and metabotropic glutamate subtype 5 receptors modulate changes in rostral ventromedial medulla neuronal activities induced by subcutaneous formalin in the rat.
Topics: Action Potentials; Analgesics; Animals; Benzoates; Benzoxazines; Chromones; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; Formaldehyde; Glycine; Injections, Subcutaneous; Male; Medulla Oblongata; Morpholines; Naphthalenes; Neurons; Pain Measurement; Periaqueductal Gray; Piperidines; Pyrazoles; Pyridines; Rats; Rats, Wistar; Reaction Time; Receptor, Cannabinoid, CB1; Receptors, Metabotropic Glutamate; Rimonabant | 2005 |